{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T11:31:23Z","timestamp":1774783883398,"version":"3.50.1"},"reference-count":14,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[1993,11,1]]},"DOI":"10.1136\/adc.69.5.577","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T22:39:16Z","timestamp":1229985556000},"page":"577-579","source":"Crossref","is-referenced-by-count":142,"title":["Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia."],"prefix":"10.1136","volume":"69","author":[{"given":"L","family":"Lennard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B E","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Nicole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J S","family":"Lilleyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity","volume":"32","author":"Weinshilboum, R.M.; Sladek, S.L.","year":"1980","unstructured":"Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651-62.","journal-title":"Am J Hum Genet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia","volume":"336","author":"Lennard, L.; Lilleyman, J.S.; Van Loon, J.A.; Weinshilboum, R.M.","year":"1990","unstructured":"Lennard L, Lilleyman JS, Van Loon JA, Weinshilboum RM. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 1990; 336: 225-9.","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bjc.1982.175","article-title":"6Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia","volume":"46","author":"Herber, S.; Lennard, L.; Lilleyman, J.S.; Maddocks, J.L.","year":"1982","unstructured":"Herber S, Lennard L, Lilleyman JS, Maddocks JL. 6Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia. BrJ Cancer 1982; 46: 138-41.","journal-title":"BrJ Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1200\/JCO.1989.7.12.1816","article-title":"Variable 6-mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukaemia","volume":"7","author":"Lennard, L.; Lilleyman, J.S.","year":"1989","unstructured":"Lennard L, Lilleyman JS. Variable 6-mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukaemia. J Clin Oncol 1989; 7: 1816-23.","journal-title":"J Clin Oncol"},{"key":"ref_5","first-page":"217","article-title":"Interaction of allopurinol with 6-mercaptopurine and azathioprine","volume":"36","author":"Brooks, R.J.; Dorr, R.T.; Durie, B.G.M.","year":"1982","unstructured":"Brooks RJ, Dorr RT, Durie BGM. Interaction of allopurinol with 6-mercaptopurine and azathioprine. Biomedicine 1982; 36: 217-22.","journal-title":"Biomedicine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-198611050-00001","article-title":"Clinical pharmacogenetics of allopurinol","volume":"11","author":"Murrell, G.A.C.; Rapeport, W.G.","year":"1986","unstructured":"Murrell GAC, Rapeport WG. Clinical pharmacogenetics of allopurinol. Clin Pharmacokinet 1986; 11: 343-53.","journal-title":"Clin Pharmacokinet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/clpt.1989.119","article-title":"Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism","volume":"46","author":"Lennard, L.; Van Loon, J.A.; Weinshilboum, R.M.","year":"1989","unstructured":"Lennard L, Van Loon JA, Weinshilboum RM. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 1989; 46: 149-54.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_8","first-page":"752","article-title":"Pancytopenia related to azathioprine - an enzyme deficiency caused by a common genetic polymorphism: a review","volume":"85","author":"Anstey, A.; Lennard, L.; Mayou, S.C.; Kirby, J.D.","year":"1982","unstructured":"Anstey A, Lennard L, Mayou SC, Kirby JD. Pancytopenia related to azathioprine - an enzyme deficiency caused by a common genetic polymorphism: a review. J R Soc Med 1982; 85:752-6.","journal-title":"J R Soc Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0022-3476(05)83063-X","article-title":"Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase deficient child with acute lymphoblastic leukaemia","volume":"119","author":"Evans, W.E.; Homer, M.; Chu, Y.Q.; Kalwinsky, D.; Roberts, W.M.","year":"1991","unstructured":"Evans WE, Homer M, Chu YQ, Kalwinsky D, Roberts WM. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase deficient child with acute lymphoblastic leukaemia. J Pediatr 1991; 119: 985-9.","journal-title":"J Pediatr"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0140-6736(93)93168-Z","article-title":"Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient","volume":"341","author":"McLeod, H.L.; Miller, D.R.; Evans, W.E.","year":"1993","unstructured":"McLeod HL, Miller DR, Evans WE. Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 1993; 341: 1151.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(92)80347-S","article-title":"High performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample","volume":"583","author":"Lennard, L.; Singleton, H.","year":"1992","unstructured":"Lennard L, Singleton H. High performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. J Chromatog 1992; 583: 83-90.","journal-title":"J Chromatog"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0009-8981(78)90311-X","article-title":"Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties","volume":"85","author":"Weinshilboum, R.M.; Raymond, F.A.; Pazmino, P.A.","year":"1978","unstructured":"Weinshilboum RM, Raymond FA, Pazmino PA. Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 1978; 85: 323-33.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"ref_13","first-page":"19","article-title":"Compliance with 6-mercaptopurine therapy in UKALL trials","volume":"84","author":"Lennard, L.; Lilleyman, J.S.","year":"1993","unstructured":"Lennard L, Lilleyman JS. Compliance with 6-mercaptopurine therapy in UKALL trials. BrJ Haematol 1993; 84 (suppl 1): 19.","journal-title":"BrJ Haematol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/bjc.1993.311","article-title":"Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?","volume":"68","author":"Lennard, L.; Davies, H.A.; Lilleyman, J.S.","year":"1993","unstructured":"Lennard L, Davies HA, Lilleyman JS. Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia? Br J Cancer 1993; 68: 186-90.","journal-title":"Br J Cancer"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.69.5.577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T21:42:37Z","timestamp":1601070157000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/adc.69.5.577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11,1]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,11,1]]}},"URL":"https:\/\/doi.org\/10.1136\/adc.69.5.577","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,11,1]]}}}